Predictors of treatment failure and outcome assessment of extracorporeal shock wave lithotripsy with the Dornier Compact Delta® III Pro: experience from the first 1000 treatments.

IF 1.3 Q3 UROLOGY & NEPHROLOGY
Archivio Italiano di Urologia e Andrologia Pub Date : 2025-06-30 Epub Date: 2025-06-10 DOI:10.4081/aiua.2025.13867
Morshed Salah, Maged Al-Ghashmi, Bela Tallai, Abu Baker, Mohammed Ibrahim, Tawiz Gul, Hatem Kamkoum, Salvan Alhabash, Hossameldin Alnawsara, Abdoulhafid Elmogassabi, Maged Alrayashi, Mohammed Ebrahim, Mohamed Abdelkareem, Faisal Ahmed
{"title":"Predictors of treatment failure and outcome assessment of extracorporeal shock wave lithotripsy with the Dornier Compact Delta® III Pro: experience from the first 1000 treatments.","authors":"Morshed Salah, Maged Al-Ghashmi, Bela Tallai, Abu Baker, Mohammed Ibrahim, Tawiz Gul, Hatem Kamkoum, Salvan Alhabash, Hossameldin Alnawsara, Abdoulhafid Elmogassabi, Maged Alrayashi, Mohammed Ebrahim, Mohamed Abdelkareem, Faisal Ahmed","doi":"10.4081/aiua.2025.13867","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Dornier Compact Delta® III Pro is a next-generation extracorporeal shock wave lithotripter featuring flat-panel detector technology for enhanced imaging and a compact modular design. This study evaluates treatment outcomes and predictors of failure for this system, representing the first published clinical experience.</p><p><strong>Methods: </strong>We retrospectively analyzed the first 1,000 consecutive patients treated with the Dornier Compact Delta® III Pro for renal or ureteric stones between May 2022 and November 2023 at a secondary hospital. Stone-free status was assessed via radiography, ultrasonography, or computed tomography (CT) within three months post-treatment. Predictive factors for treatment failure were identified through univariate and multivariate logistic regression analyses.</p><p><strong>Results: </strong>The cohort had a median age of 37 years (IQR: 32- 44.2) and a body mass index (BMI) of 26 kg/m² (IQR: 24-29). Key characteristics included: prior urologic interventions in 36.6% of patients, single stones in 79.8% (median size 9 mm, IQR: 7-10), a median stone density of 1000 Hounsfield Units (HU) (IQR: 760-1200), and hydronephrosis observed in 55.3% of cases. Initial ESWL success was achieved in 80.5% of cases, increasing to 87.5% following repeat sessions (mean treatments: 1.2). Multivariate analysis identified four independent predictors of treatment failure: prior urologic intervention (adjusted odds ratio [aOR] 2.64, 95% CI 1.75-4.00, p<0.001), multiple stones (aOR 0.45, 95% CI 0.24-0.77, p = 0.011), increased skin-to-stone distance (per cm: aOR 1.18, 95% CI 1.06-1.30, p<0.001), and higher stone density (per 100 HU: aOR 1.12, 95% CI 1.06-1.18, p<0.001).</p><p><strong>Conclusions: </strong>The Dornier Compact Delta® III Pro achieved an 87.3% stone-free rate with failure predictors consistent with established lithotripsy literature. These findings support the adoption of this device as an effective ESWL system, particularly for institutions prioritizing advanced imaging and a space-efficient design.</p>","PeriodicalId":46900,"journal":{"name":"Archivio Italiano di Urologia e Andrologia","volume":" ","pages":"13867"},"PeriodicalIF":1.3000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivio Italiano di Urologia e Andrologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4081/aiua.2025.13867","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The Dornier Compact Delta® III Pro is a next-generation extracorporeal shock wave lithotripter featuring flat-panel detector technology for enhanced imaging and a compact modular design. This study evaluates treatment outcomes and predictors of failure for this system, representing the first published clinical experience.

Methods: We retrospectively analyzed the first 1,000 consecutive patients treated with the Dornier Compact Delta® III Pro for renal or ureteric stones between May 2022 and November 2023 at a secondary hospital. Stone-free status was assessed via radiography, ultrasonography, or computed tomography (CT) within three months post-treatment. Predictive factors for treatment failure were identified through univariate and multivariate logistic regression analyses.

Results: The cohort had a median age of 37 years (IQR: 32- 44.2) and a body mass index (BMI) of 26 kg/m² (IQR: 24-29). Key characteristics included: prior urologic interventions in 36.6% of patients, single stones in 79.8% (median size 9 mm, IQR: 7-10), a median stone density of 1000 Hounsfield Units (HU) (IQR: 760-1200), and hydronephrosis observed in 55.3% of cases. Initial ESWL success was achieved in 80.5% of cases, increasing to 87.5% following repeat sessions (mean treatments: 1.2). Multivariate analysis identified four independent predictors of treatment failure: prior urologic intervention (adjusted odds ratio [aOR] 2.64, 95% CI 1.75-4.00, p<0.001), multiple stones (aOR 0.45, 95% CI 0.24-0.77, p = 0.011), increased skin-to-stone distance (per cm: aOR 1.18, 95% CI 1.06-1.30, p<0.001), and higher stone density (per 100 HU: aOR 1.12, 95% CI 1.06-1.18, p<0.001).

Conclusions: The Dornier Compact Delta® III Pro achieved an 87.3% stone-free rate with failure predictors consistent with established lithotripsy literature. These findings support the adoption of this device as an effective ESWL system, particularly for institutions prioritizing advanced imaging and a space-efficient design.

使用多尼尔Compact Delta®III Pro进行体外冲击波碎石治疗失败的预测因素和结果评估:前1000例治疗的经验
背景:多尼尔Compact Delta®III Pro是下一代体外冲击波碎石机,具有平板探测器技术,可增强成像和紧凑的模块化设计。这项研究评估了该系统的治疗结果和失败的预测因素,代表了首次发表的临床经验。方法:我们回顾性分析了2022年5月至2023年11月在一家二级医院连续使用多尼尔Compact Delta®III Pro治疗肾脏或输尿管结石的前1000例患者。治疗后三个月内通过x线摄影、超声检查或计算机断层扫描(CT)评估无结石状态。通过单因素和多因素logistic回归分析确定治疗失败的预测因素。结果:该队列的中位年龄为37岁(IQR: 32- 44.2),体重指数(BMI)为26 kg/m²(IQR: 24-29)。主要特征包括:36.6%的患者有泌尿系统干预史,79.8%的患者有单一结石(中位尺寸为9 mm, IQR: 7-10),中位结石密度为1000 Hounsfield单位(HU) (IQR: 760-1200), 55.3%的患者有肾积水。初始ESWL成功率为80.5%,重复治疗后增加到87.5%(平均治疗次数:1.2次)。多因素分析确定了治疗失败的四个独立预测因素:既往泌尿系统干预(调整优势比[aOR] 2.64, 95% CI 1.75-4.00)。结论:Dornier Compact Delta®III Pro无结石率达到87.3%,失败预测因素与已有的碎石文献一致。这些发现支持采用该设备作为有效的ESWL系统,特别是对于优先考虑先进成像和节省空间设计的机构。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.10
自引率
35.70%
发文量
72
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信